Drug intelligence / Profile preview

Phloretin

Development stage
Preclinical
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral
01

Overview

Phloretin is a natural dihydrochalcone flavonoid found in apples, strawberries, and other fruits. It exhibits a range of biological activities including antioxidant, anti-inflammatory, anticancer, antibacterial, and organ-protective effects[1][3][4][5]. Mechanistically, phloretin inhibits glucose transporters SGLT1 and SGLT2 (though less potently than its glycoside phlorizin), reducing intestinal glucose absorption and renal reabsorption[5]. It also inhibits urea transporters and aquaporin 9 (AQP9), modulates the NF-κB signaling pathway to suppress inflammatory cytokines (such as TNF-α, IL-6), induces Nrf2 expression for antioxidant defense[8], increases cell membrane permeability in bacteria leading to antibacterial effects[6], and induces apoptosis in various cancer cell lines by affecting apoptotic proteins such as Bcl-2 family members[7]. Phloretin is primarily studied experimentally for potential therapeutic applications against cancers, diabetes complications (including cardiomyopathy and neuropathy), liver/kidney injury, ulcerative colitis, asthma, arthritis, cognitive impairment as well as microbial infections[3][4].

Other names
dihydrochalcone2',4,4',6'-tetrahydroxy-dihydrochalcone
02

Targets

AQP9 (Aquaporin-9)MCL1 (Myeloid cell leukemia sequence 1)PPARG (Peroxisome proliferator-activated receptor gamma)SLC5A1 (Sodium Glucose Cotransporter 1)SGLT2 (Sodium-glucose cotransporter protein subunit 2)UGT1A1 (UDP-glucuronosyltransferase 1A1)UGT1A7 (UDP-glucuronosyltransferase 1A7)UGT2B15 (UDP-glucuronosyltransferase 2B15)BCL-2 (BCL-2 family)NF-κB

Beyond the preview

Go deeper on Phloretin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phloretin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call